Hongxia Ding

Title: Innovations and Contributions of Inventor Hongxia Ding

Introduction

Hongxia Ding is a notable inventor based in Beijing, China. He has made significant contributions to the field of cancer treatment through his innovative research and development of new pharmaceutical compositions. With a total of three patents to his name, Ding's work focuses on utilizing natural compounds for therapeutic purposes.

Latest Patents

One of his latest patents is titled "Use of Icaritin for the preparation of composition for treating cancer." This invention provides a method for using Icaritin, which is administered orally to patients in a structured 28-day dosing schedule. The treatment aims to improve patient outcomes while minimizing adverse effects. Another significant patent is "Synthesis of polyhydroxy chromenone compounds and their anti-tumor effects." This invention involves chromenone compounds that can modulate the function of estrogen receptors, offering potential treatments for estrogen-related diseases such as breast cancer and leukemia.

Career Highlights

Hongxia Ding has worked with Beijing Shenogen Pharma Group Ltd., where he has contributed to the development of innovative cancer therapies. His expertise in pharmaceutical sciences has positioned him as a key figure in the research community.

Collaborations

Ding has collaborated with notable colleagues, including Kun Meng and Jin Li, who have supported his research endeavors. Their combined efforts have advanced the understanding of cancer treatment options.

Conclusion

Hongxia Ding's innovative work in cancer treatment through his patents demonstrates his commitment to improving patient care. His contributions to the field highlight the importance of research and collaboration in developing effective therapies.